Back
GT Biopharma, Inc. Stock Price Chart
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
9
GTBP
GT Biopharma, Inc.
Last Price:
$0.63
Seasonality Move:
-1.64%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight buying pressure.
GT Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.73 | Sell |
| 20-day SMA: | 0.71 | Sell |
| 50-day SMA: | 0.7 | Sell |
| 200-day SMA: | 1.77 | Sell |
| 8-day EMA: | 0.7 | Sell |
| 20-day EMA: | 0.71 | Sell |
| 50-day EMA: | 0.79 | Sell |
| 200-day EMA: | 1.65 | Sell |
GT Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 43.28 | Sell |
| Chaikin Money Flow: | 287508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.77) | Sell |
| Bollinger Bands (100): | (0.55 - 1.53) | Sell |
GT Biopharma, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for GT Biopharma, Inc. Stock
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.63 while GTBP 8-day simple moving average is 0.73, which is a Sell signal.
-
The stock price of GTBP is 0.63 while GT Biopharma, Inc. 20-day SMA is 0.71, which makes it a Sell.
-
GT Biopharma, Inc. 50-day simple moving average is 0.70 while GTBP share price is 0.63, making it a Sell technically.
-
GTBP stock price is 0.63 and GT Biopharma, Inc. 200-day simple moving average is 1.77, creating a Sell signal.
GTBP Technical Analysis vs Fundamental Analysis
Sell
9
GT Biopharma, Inc. (GTBP)
is a Sell
Is GT Biopharma, Inc. a Buy or a Sell?
-
GT Biopharma, Inc. stock is rated a SellThe current GT Biopharma, Inc. [GTBP] share price is $0.63. The Score for GTBP is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
GT Biopharma, Inc. Stock Info
Market Cap:
6.7M
Price in USD:
0.63
Share Volume:
1.6M
GT Biopharma, Inc. 52-Week Range
52-Week High:
4.10
52-Week Low:
0.54
Sell
9
GT Biopharma, Inc. (GTBP)
is a Sell
GT Biopharma, Inc. Share Price Forecast
-
What is the GT Biopharma, Inc. stock price today?The GT Biopharma, Inc. stock price is 0.63 USD today.
-
Will GTBP stock go up or go down?GT Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is GT Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, GT Biopharma, Inc. is overvalued.
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.63 while GTBP 8-day exponential moving average is 0.70, which is a Sell signal.
-
The stock price of GTBP is 0.63 while GT Biopharma, Inc. 20-day EMA is 0.71, which makes it a Sell.
-
GT Biopharma, Inc. 50-day exponential moving average is 0.79 while GTBP share price is 0.63, making it a Sell technically.
-
GTBP stock price is 0.63 and GT Biopharma, Inc. 200-day simple moving average is 1.65, creating a Sell signal.
Fundamental Analysis of GT Biopharma, Inc.
Is GT Biopharma, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.93 per share.
Technical Analysis of GT Biopharma, Inc.
Should I short GT Biopharma, Inc. stock?
-
GTBP Moving Average Covergence Divergence (MACD) indicator is -0, suggesting GT Biopharma, Inc. is a Sell
-
GT Biopharma, Inc. Relative Strength Index (RSI) is 43.28, which suggest GT Biopharma, Inc. is oversold
-
The Bollinger Bands (25) for GT Biopharma, Inc. is (0.61 - 0.77), which suggest GT Biopharma, Inc. is a Sell
-
The Bollinger Bands (100) for GT Biopharma, Inc. is (0.55 - 1.53), which suggest GT Biopharma, Inc. is a Sell
* GT Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.